O-AD05 Atopic Dermatitis (Eczema) Pre-Screener Questionnaire
We are currently recruiting subjects aged 18 to 75 years with moderate to severe Atopic Dermatitis (Eczema) to take part in a research study. The primary objective of the study is to assess the efficacy (how well the study drug works) and safety of an investigational monoclonal antibody called OpSCF.
Compensation may be provided for time and travel - participation in this study will come at no cost to you.
Visits: 22 visits + 2 follow-ups (1 in-person visit and 1 follow-up phone call)
Study Length: approx. ~71 weeks (about 16 ½ months)
Please answer the following questionnaire to the best of your ability. It should take approximately 4 - 6 minutes to complete.
* Questions with a red star are mandatory.
Start Questionnaire
